Kirkland & Ellis advised KKR on the transaction, and Foley & Lardner advised Avantus. KKR, a leading global investment firm, announced the signing of a definitive...
KKR’s Acquisition of Majority Stake in Avantus
Baker Tilly’s Capital Raise
Baker Tilly engaged William Blair & Company, L.L.C. as its financial advisor and Foley & Lardner LLP as its legal counsel on this transaction. Simpson Thacher...
Bluestone Equity Partners’ Investment into PMY Group
Foley & Lardner LLP advised Bluestone Equity Partners on the deal. Bluestone Equity Partners (Bluestone), the global sports, media, and entertainment (SME) private equity firm, announced...
Jamf’s Acquisition of ZecOps
Foley & Lardner LLP advised ZecOps on the deal. ZecOps, a leader in mobile detection and response, announced its acquisition by Jamf, the standard in Apple Enterprise...
Eyenuk’s $26 Million Series A Financing Round
Foley & Lardner LLP represented AXA IM Alts on the deal. AXA IM Alts, a global leader in alternative investments, acted as lead investor in the $26...
Material Newborn Health Innovations’ $26 Million Financing Round
Foley & Lardner LLP represented AXA IM Alts on the deal. AXA IM Alts, a global leader in alternative investments with over $190 billion of assets...
CXL Ophthalmics’ $32 Million Series A Round of Fundraising
Mintz represented CXL Ophthalmics (CXLO) on the deal while Foley & Lardner LLP represented AXA IM Alts. CXL Ophthalmics (CXLO), a clinical-stage company developing a minimally-invasive...
Aceto’s Acquisition of Biotron Laboratories and Talus Mineral Company
Foley & Lardner LLP advised Biotron Laboratories and Talus Mineral Company on the deal. Biotron Laboratories and Talus Mineral Company (collectively “Biotron”), two affiliated entities that...
BICO Group’s $165 Million Acquisition of Biosero, Inc.
Foley & Lardner advised BICO Group on the deal. Boston-based bio convergence company BICO Group AB (“BICO”) announced its acquisition of Biosero, Inc. (“Biosero”), a San Diego-based...